SCHEMBL29455808

SCHEMBL29455808

C=CCn1cc(B2OC(C)(C)C(C)(C)O2)c2ccn(S(=O)(=O)c3ccc(C)cc3)c2c1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 6/20 0.36
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ELANE P08246 1/20 0.34
PRTN3 P24158 1/20 0.34
HTR6 P50406 2/20 0.33
KDM4E B2RXH2 1/20 0.32
UBE2N P61088 1/20 0.32
RAPGEF4 Q8WZA2 1/20 0.32
VEGFA P15692 2/20 0.31
EGLN1 Q9GZT9 2/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
CYP19A1 P11511 1/20 0.31
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31
KMT2A Q03164 1/20 0.31
PKM P14618 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17749753 0.91 BRD4 (0.37) BRD4ALDH1A1SMN1; SMN2ELANEPRTN3
SCHEMBL17749823 0.91 BRD4 (0.36) BRD4ALDH1A1SMN1; SMN2ELANEPRTN3
SCHEMBL17749821 0.91 BRD4 (0.36) BRD4ALDH1A1SMN1; SMN2ELANEPRTN3
SCHEMBL29455869 0.88 BRD4 (0.38) BRD4ALDH1A1SMN1; SMN2ELANEPRTN3
SCHEMBL15069430 0.83 BRD4 (0.48) BRD4ELANEPRTN3HTR6KDM4E
SCHEMBL23358174 0.81 BRD4 (0.42) BRD4ELANEPRTN3HTR6KDM4E
SCHEMBL17758546 0.80 CA1 (0.42) BRD4ALDH1A1SMN1; SMN2HTR6KDM4E
SCHEMBL29455995 0.80 BRD4 (0.37) BRD4ELANEPRTN3HTR6KDM4E
SCHEMBL31395395 0.79 BRD4 (0.41) BRD4ELANEPRTN3HTR6KDM4E
SCHEMBL19642608 0.76 L3MBTL1 (0.39) BRD4SMN1; SMN2ELANEPRTN3HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12636290-B2 BET inhibitors for modulating DUX4 expression in FSHD SAINT LOUIS UNIVERSITY (US) 2026-05-26 US disclosed
US-20220079951-A1 BET INHIBITORS FOR MODULATING DUX4 EXPRESSION IN FSHD SAINT LOUIS UNIVERSITY (US) 2022-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220079951-A1 BET INHIBITORS FOR MODULATING DUX4 EXPRESSION IN FSHD BRDT, PHKB, BET1 BRD4 4/4885ALDH1A1 4466/4885SMN1; SMN2 1146/4885
US-12636290-B2 BET inhibitors for modulating DUX4 expression in FSHD BRDT, BET1, PHKB BRD4 6/4885ALDH1A1 3913/4885SMN1; SMN2 1421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.